RxDoctor Payments DataLook up a doctor →

Clint Behrend, MD

Gastroenterology · Idaho Falls, IDNPI 1538138243

Payments from drug & device makers

$822,897in general payments, 2019–2025

Across 381 payments — averaging $2159.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$408K
  • Takeda Pharmaceuticals U.S.A., Inc.$133K
  • Genentech, Inc.$82K
  • Janssen Research & Development, LLC$66K
  • AbbVie$55K
  • F. Hoffmann-la Roche AG$35K
  • plus $44K from 31 others
$9,190in research payments, 2019–2025

Across 7 payments — averaging $1312.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$9K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$822,897 in reported general payments places this provider in the 95th percentile of 70 gastroenterology providers in Idaho.

See all gastroenterology providers in Idaho

Medicare billing

Part B allowed, 2024
$107,689
Medicare patients
470
Services billed
916

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →